66 Antonio Bargellesi/Maria Colnaghi: Gli anticorpi monoclonali in oncologia. 2 Le Scienze, 53-58. S. Baskar a.o.: Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Nat. Ac. Sci. USA 90 (1993), 5687-... W. Bodmer a.o.: Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann. NY Ac. Sci. 690 (1993), 42-... T. Boon/T. Gajewski/P. Coulie: From defined human tumor antigenes to effective immunization? Imm. Today 16 (1995), 334-... T. Boon a.o.: Tumor antigens recognized by T lymphocytes. Ann. Rev. Imm. 12 (1994), 337-... L. Chen a.o.: Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71 (1992), 1093-... L. Chen a.o.: Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179 (1994), 523-... 3110 D. Chowdhury/M. Sahimi/D. Stauffer: A discrete model for immune surveillance, tumour immunity and cancer. J. Theor. Biol. 152 (1991), 263-270. [4373] W. Den Otter/E. Ruitenberg: Tumor immunology - mechanisms, diagnosis, therapy. Elsevier 1987. O. Finn a.o.: MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Imm. Rev. 145 (1995), 61-... F. Garrido a.o.: Natural history of HLA expression during tumour development. Imm. Today 14 (1993), 491-... T. Hamilton/D. Adams: Mechanisms of macrophage-mediated tumor injury. In Den Otter/Ruitenberg 1987, 89-... M. Heike a.o.: Membranes activate tumor- and virus-specific precursor cytotoxic T lymphocytes in vivo and stimulate tumor-specific T lymphocytes in vitro - implications for vaccination. J. Immunother. Emph. Tumor Imm. 15 (1994), 165-... A. Huang a.o.: Role of bone marrow-derived cells in presenting MHC class I- restricted tumor antigens. Science 264 (1994), 961-... M. Jakobsen a.o.: Defective major histocompatibiliy complex class I expression in a sarcomatoid renal cell carcinoma cell line. J. Immunother. Emph. Tumor Imm. 17 (1995), 222-... X. Kang a.o.: Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J. Imm. 155 (1995), 1343-... Sabine von Kleist (ed.): Basic research and clinical application in human tumor immunology and molecular biology. Karger 1995. 3-8055-6147-4. DM 65. P. Kourilsky/C. Jaulin/V. Ley: The structure and function of MHC molecules. Possible implications for the control of tumor growth by MHC-restricted T cells. Sem. Cancer Biol. 2 (1991), 275-... 4939 Alberto Mantovani/Franco Dammacco: Immunologia dei tumori. 2 Le Scienze, 47-52. F. Marincola a.o.: Locus-specific analysis of human leucocyte antigen class I expression in melanoma cell lines. J. Immunother. Emph. Tumor Imm. 16 (1994), 13-... F. Marincola a.o.: Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J. Imm. 153 (1994), 1225-... Bohuslav Melichar a.o.: Mitogen-induced lymphocyte proliferation and systemic immune activation in cancer patients. Tumori 82/3 (1996), ... P. Paglia/C. Chiodoni/M. Rodolfo/M. Colombo: Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183 (1996), 317-... 3657 Giorgio Parmiani/Franco Dammaco: Interleuchina 2 e interferoni in oncologia. 2 Le Scienze, 82-89. 1071 Ju''rgen Pepping/Christian Witting: Biomolekulare Aspekte bo''sartiger Tumoren. Thieme 1982. M. Potter: Neoplastic development in B-lymphocytes. Carcinogenesis 11 (1990), 1-... R. Prehn/J. Main: Immunity to methylcholcholanthrene-induced sarcomas. J. NCI 18 (1957), 769-... Nicholas Restifo a.o.: Identification of human cancers deficient in antigen processing. J. Exp. Med. 177 (1993), 265-... Adrian Robins/Robert Rees (ed.): Cancer immunology. Kluwer 2001, 280p. $74. 4341 Steven Rosenberg/John Barry: Die vera''nderte Zelle. Goldmann 1992. English as "The transformed cell" from Putnam. One would be happier, if this were a description of palaolithic, not of today's cancer research. D. Ruiter/V. Mattijssen/E. Broecker/S. Ferrone: MHC antigens in human melanomas. Sem. Cancer Biol. 2 (1991), 35-... F. Ruiz-Cabello a.o.: Molecular analysis of MHC-class-I alterations in human tumor cell lines. Int. J. Cancer Suppl. 6 (1991), 123-... 20243 Gary Stix: Bösartige Entzündungen. Spektrum 2008/4, 50-57. Krebszellen mißbrauchen die Wundheilung für ihre Zwecke. S. Townsend/J. Allison: Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259 (1993), 368-... H. Udono/D. Levey/P. Srivastava: Cellular requirements for tumor-specific immunity elicited by heat shock proteins - tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc. Nat. Ac. Sci. USA 91 (1994), 3077-... H. Udono/P. Srivastava: Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med. 178 (1993), 1391-... T. Whiteside/R. Herberman: The role of natural killer cells in immune surveillance of cancer. Curr. Op. Imm. 7 (1995), 704-... 8782 Nigel Williams: Tumor cells fight back to beat immune system. Science 22 November 1996, 1302.